MDS lose C$10m to FDA review in Q4
MDS has been heavily impacted by a US Food and Drug Administration procedural review of its bioanalytical operations, but still managed to report quarterly earnings of C$53m (€35m).
Archives for December 18, 2006
PACS stem cell purifier
New stem cell purification technology allows fast and accurate purification.
Antisense drugs stop making sense?
The once hyped antisense sector of the pharmaceutical industry has again proved a disappointment after one drug in development was refused approval and another was scrapped.
Patheon limps in with end of year results
Patheon last week announced its fourth quarter and end of year financial results after a tough year for the contract drug manufacturer.
Solvay deal suggests Novasep's strategy has paid off
Solvay has contracted Novasep to provide synthesis of two active pharmaceutical ingredients, following Novasep's decision to combine synthesis and processing expertise.
Shire to get European approval for its ulcerative colitis drug
Pharma company Shire has agreed with European regulators on labelling information for its ulcerative colitis drug Mezavant, a further step in the firm's ambition to capture more of the $1.6bn (€1.2bn) mesalazine market through its easy and effective...
MonoSolRx's thin film drug delivery system attracts investors
Drug delivery company MonoSolRx has announced it has received a $38m (€29m) funding from an investment group, illustrating the appeal of the company's dissolving film technology.
Dr Reddy's increases its manufacturing capacity
Dr Reddy's Laboratories has boosted its ability to serve Western pharmaceutical markets with an increase in its manufacturing capacity for drug formulations.
EU chemical law passed amid controversy
EU lawmakers have approved a new chemical law aimed at making producers and importers of chemicals, used in goods such as personal care products, prove that the substances they put on the market are safe for consumers.